Details for New Drug Application (NDA): 018761
✉ Email this page to a colleague
The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.
Summary for 018761
Tradename: | ALUPENT |
Applicant: | Boehringer Ingelheim |
Ingredient: | metaproterenol sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018761
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION | Strength | 0.6% | ||||
Approval Date: | Jun 30, 1983 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION | Strength | 0.4% | ||||
Approval Date: | Oct 10, 1986 | TE: | RLD: | No |
Expired US Patents for NDA 018761
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | ALUPENT | metaproterenol sulfate | SOLUTION;INHALATION | 018761-001 | Jun 30, 1983 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription